Skip to content

Upper Trunk Block Versus Costoclavicular Block For Arthroscopic Shoulder Surgery

Comparison of Perioperative Analgesic Efficacy of Ultrasonography Guided Upper Trunk Block and Costoclavicular Infraclavicular Brachial Plexus Block in Arthroscopic Shoulder Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04194385
Enrollment
50
Registered
2019-12-11
Start date
2020-05-10
Completion date
2023-06-30
Last updated
2023-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain, Phrenic Nerve Paralysis

Keywords

bupivacaine, costoclavicular block, upper trunk block

Brief summary

Interscalene brachial plexus block is known as the gold standard for analgesia after shoulder surgery, but limits the use of ipsilateral phrenic nerve paralysis. Recently, interest in potential diaphragm-sparing alternative blocks has increased for patients undergoing shoulder surgery.Two of these blocks are upper trunk block (UTB) and costoclavicular brachial plexus (CCBPB) block. This randomized controlled trial will compare ultrasound-guided UTB and CCBPB in patients undergoing arthroscopic shoulder surgery. The main outcome is pain intensity score at 30 minutes after arrival in the post anesthesia care unit (PACU) as measured by a numerical rating scale (NRS) from 0 to 10. The investigators research hypothesis is that UTB and CCBPB will result in equivalent postoperative analgesia at 30 minutes in the PACU.

Interventions

PROCEDUREUpper trunk block

Block will be applied to supraclavicular zone by 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine .

Block will be applied to infraclavicular zone by 20 ml % 0.25 bupivacaine with 5 mcg/ml epinephrine.

Diaphragmatic excursion will be assessed under ultrasound immediately before and after regional anesthesia.

PROCEDURECervical plexus blockade

Block will be applied at thyroid cartilage level via 10 ml % 0.25 bupivacaine.

Sponsors

Bezmialem Vakif University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. American Association of Anesthesiologists (ASA) physical status I - III 2. BMI 20 to 35 kg / m2 3. Patients scheduled for elective arthroscopic shoulder surgery

Exclusion criteria

1. Patients who refuse to participate in the study, 2. Pre-existing (obstructive or restrictive) lung disease, 3. Coagulopathy, 4. Sepsis, 5. Hepatic or renal insufficiency, 6. Pregnancy 7. Allergy to local anesthetic drugs, 8. Chronic pain condition requiring opioid intake at home, 9. Surgery in the neck or infraclavicular region 10. BMI above 40. 11. History of psychiatric diseases needing treatment. 12. Failure of nerve block performed in the preoperative block room 13. Substance abuse history

Design outcomes

Primary

MeasureTime frameDescription
Detection of diaphragmatic paralysis by ultrasonography30 minutes after block applicationIpsilateral diaphragmatic excursion 30 minutes after block completion

Secondary

MeasureTime frameDescription
Pain intensity score30 minutes, 1,3, 6, 12, 24 hour after surgeryPostoperative pain assessed with verbal rating scale (VRS 0: no pain 10:pain as bad as can be )
Block perform timeThe time from the needle enters the skin until the block is completedBlock application time will be recorded
Postoperative opioid consumption24 hour after surgeryTotal amount of tramadol consumption during the first 24 hours after surgery. Patient controlled analgesia to be inserted.
Intraoperative fentanyl requirementFrom the beginning to the end of the operationDuring the operation, 0.5 μg/kg fentanyl was administered to the patient in case of a 20% increase in the mean blood pressure and heart rate compared to the baseline values
Patient satisfaction: NRS24 hour after surgeryPatient satisfaction measured using a NRS 0 to 10 (0 = unsatisfied; 10 =very satisfied)
Block onset timeUntil sensory and motor block occursBlock onset time will be evaluated and recorded.

Countries

Turkey (Türkiye)

Contacts

Primary ContactSerdar Yeşiltaş, Instructor
syesiltas@bezmialem.edu.tr+90 542 363 26 30

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026